[Editorial] Who owns cardiometabolic disease?

A person with obesity, type 2 diabetes, chronic kidney disease, metabolic dysfunction-associated steatotic liver disease, and heart failure might receive five different diagnoses, attend five different clinics, and be managed according to five different guidelines.

But these conditions are not independent, they often accumulate along connected pathways shaped by adiposity, insulin resistance, inflammation, and vascular dysfunction.

This shared trajectory is increasingly difficult to ignore, as the Lancet Series on cardiometabolic multiple long-term conditions shows. ...